UBS O'Connor’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-77,065
Closed -$40K 646
2021
Q4
$40K Buy
77,065
+2,067
+3% +$1.32K ﹤0.01% 919
2021
Q3
$47K Hold
74,998
﹤0.01% 892
2021
Q2
$69K Hold
74,998
﹤0.01% 852
2021
Q1
$47K Buy
+74,998
New +$92.2K ﹤0.01% 794

Other funds holding HCARW

UBS O'Connor's HCARW Position: Q1 2022 in Review

UBS O'Connor sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q1 2022, closing a stake of 77,065 shares — an estimated $40K sold.

UBS O'Connor first reported a position in HCARW in Q1 2021 and held it in 4 quarters. The position peaked at $69K in Q2 2021. 46 funds tracked by Wall St. Rank hold HCARW as of Q1 2022.

  • UBS O'Connor reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 77,065 Healthcare Services Acquisition Corporation Warrant shares in Q1 2022, an estimated $40K.
  • UBS O'Connor first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Healthcare Services Acquisition Corporation Warrant position peaked at $69K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.